HomeFileStructural heart disease

Structural heart disease

SOLACI-CACI 2021 | PICS-AICS Session

✔️ Watch the PICS-AICS session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 02:07 - Initial Experience with...

SOLACI-CACI 2021 | EuroPCR Session

✔️ Watch the complete PCR in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 👉 How to manage Coronary...

SOLACI-CACI 2021 | Current Controversies in Post-TAVR CORONARY ACCESS – Medtronic Symposium

✔️ MEDTRONIC Symposium in the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: Current Controversies in Post-TAVR CORONARY ACCESS.  👨‍🏫 Program:...

ESC 2021 | ENVISAGE-TAVI AF: Surprise with Endoxaban in TAVR and Atrial Fibrillation

The enthusiasm for direct oral anticoagulants after transcatheter aortic valve replacements (TAVR) is waning. At least, when...

ESC 2021 | Updated European Society of Cardiology Guidelines for the Management of Valvular Heart Disease

Early intervention in asymptomatic valvular heart disease, age recommendations to decide between TAVR and surgery for aortic...

New Markers of Aortic Stenosis Define Asymptomatic Patients

Asymptomatic aortic stenosis has been keeping us in tense stillness. However, there are new markers capable of...

TAVR Durability Becomes Irrelevant after TRANSIT Outcomes

The international registry TRANSIT has shown treating degenerated transcatheter aortic valves (TAVs) with a second TAVR is...